Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Odile Joly"'
Publikováno v:
Développement Durable et Territoires, Vol 2, Iss 1
The aim of this article is: to point out and to clarify some « gaps » which can be observed between the thinking and acting categories of some public protagonists working towards the Factor 4 scenario, and the reflexive and practical rationalities
Externí odkaz:
https://doaj.org/article/2f558079eadc45759fa754429d11c839
Autor:
Caroline Kientz, Marie-Odile Joly, Laurence Faivre, Alix Clemenson, Sophie Dalac, Côme Lepage, Caroline Chapusot, Caroline Jacquot, Renaud Schiappa, Marine Lebrun
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 15, Iss 1, Pp 1-4 (2017)
Abstract Background The tumor spectrum in the Lynch syndrome is well defined, comprising an increased risk of developing colonic and extracolonic malignancies. Muir-Torre syndrome is a variant with a higher risk of skin disease. Patients have been de
Externí odkaz:
https://doaj.org/article/7d02ade405f34cb29ce637ad88e533e9
Autor:
Jacques Guyotat, Véronique Bourg, Anne Jouvet, François Ducray, Fanny Burel-Vandenbos, Jérôme Honnorat, Fabien Forest, Alexandra Amiel-Benouaich, David Meyronet, Tanguy Fenouil, Maud Esteban-Mader, Charlotte Bonnet, Emmanuelle Uro-Coste, Cécilia Rousselot-Denis, Marie-Odile Joly
Publikováno v:
Neuro-Oncology. 19:1127-1134
Background Diffuse H3 K27M-mutant gliomas occur primarily in children but can also be encountered in adults. The aim of this study was to describe the characteristics of H3 K27M-mutant gliomas in adults. Methods We analyzed the characteristics of 21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b100e6ae55183ab519310c6393e65e06
https://doi.org/10.1093/neuonc/now274
https://doi.org/10.1093/neuonc/now274
Autor:
Valérie Hervieu, Marie-Odile Joly, Thomas Walter, Jean-Christophe Saurin, Marco Petronio, Stéphane Pinson, Julien Forestier
Publikováno v:
United European Gastroenterology Journal. 4:305-313
The aim of this article is to clarify the epidemiologic, clinical, endoscopic, biological and genetic characteristics of type 1 serrated polyposis patients.Consecutive patients responding to the WHO definition of type 1 serrated polyposis in one refe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeae2fd0d8fe9d768d4c2bce814ca230
https://doi.org/10.1177/2050640615594939
https://doi.org/10.1177/2050640615594939
Autor:
Marie-Odile Joly, Colette Roche, Valérie Hervieu, Patrick Massoma, Thomas Walter, Nicolas Gadot, Julien Bollard, Martine Blanc, Florian Lepinasse, Christophe Couderc, Jean-Yves Scoazec, Cécile Vercherat, Gilles Poncet
Publikováno v:
Oncotarget
// Julien Bollard 1, * , Patrick Massoma 1, * , Cecile Vercherat 1 , Martine Blanc 1 , Florian Lepinasse 2 , Nicolas Gadot 3 , Christophe Couderc 1 , Gilles Poncet 4 , Thomas Walter 4 , Marie-Odile Joly 1, 2, 5 , Valerie Hervieu 1, 2, 5 , Jean-Yves S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f22db8e1cc9ed8f358a6abb4b0465a4
https://doi.org/10.18632/oncotarget.5481
https://doi.org/10.18632/oncotarget.5481
Autor:
Julien Forestier, Jean-Yves Scoazec, Cécile Vercherat, Valérie Hervieu, Thomas Walter, Marie-Odile Joly, Catherine Lombard-Bohas, Anne-Sophie Dussol
Publikováno v:
Cancer. 121:3428-3434
BACKGROUND The alkylating agents (ALKYs) streptozotocin, dacarbazine, and temozolomide currently are the main drugs used in systemic chemotherapy for neuroendocrine tumors (NETs). The promising activity shown by gemcitabine and oxaliplatin (GEMOX) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::597ee7c0f8c8850b7de80fe06717b355
https://doi.org/10.1002/cncr.29517
https://doi.org/10.1002/cncr.29517
Autor:
Sophie Dalac, Laurence Faivre, Renaud Schiappa, Alix Clemenson, Marie-Odile Joly, Côme Lepage, Marine Lebrun, Caroline Kientz, Caroline Chapusot, Caroline Jacquot
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, BioMed Central, 2017, 15 (1), pp.6. ⟨10.1186/s13053-017-0066-9⟩
Hereditary Cancer in Clinical Practice, BioMed Central, 2017, 15 (1), pp.6. 〈https://hccpjournal.biomedcentral.com/articles/10.1186/s13053-017-0066-9〉. 〈10.1186/s13053-017-0066-9〉
Hereditary Cancer in Clinical Practice, Vol 15, Iss 1, Pp 1-4 (2017)
Hereditary Cancer in Clinical Practice, BioMed Central, 2017, 15 (1), pp.6. ⟨10.1186/s13053-017-0066-9⟩
Hereditary Cancer in Clinical Practice, BioMed Central, 2017, 15 (1), pp.6. 〈https://hccpjournal.biomedcentral.com/articles/10.1186/s13053-017-0066-9〉. 〈10.1186/s13053-017-0066-9〉
Hereditary Cancer in Clinical Practice, Vol 15, Iss 1, Pp 1-4 (2017)
IF 1.590; International audience; Background: The tumor spectrum in the Lynch syndrome is well defined, comprising an increased risk of developing colonic and extracolonic malignancies. Muir-Torre syndrome is a variant with a higher risk of skin dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ca8f11ddad5673a992a7190e085bef4
https://hal.archives-ouvertes.fr/hal-01541073
https://hal.archives-ouvertes.fr/hal-01541073
Autor:
Françoise Cattin, Marie Odile Joly, Alexandre Vasiljevic, Séverine Valmary-Degano, Gabriel Viennet, Anne Jouvet
Publikováno v:
Annales de Pathologie. 34:477-480
Cerebellar gangliocytoma can correspond to Lhermitte-Duclos disease, a benign hamartomatous malformation encountered in young adults. It can also be a part of gangliogliomas/gangliocytomas family, which usually encompasses temporal pediatric neoplasm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fddc58e2f5b9f845be0ccfdb25689600
https://doi.org/10.1016/j.annpat.2014.09.008
https://doi.org/10.1016/j.annpat.2014.09.008
Autor:
David Meyronet, Charlotte Bonnet, J Guyotat, François Ducray, Fabien Forest, Anne Jouvet, M. Esteban Mader, Jérôme Honnorat, Marie-Odile Joly, Emmanuelle Uro-Coste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::686bce7e693bc107c47cf05a3c613e79
https://europepmc.org/articles/PMC5782668/
https://europepmc.org/articles/PMC5782668/
Autor:
Véronique Quillien, Olivier Chinot, Dominique Figarella-Branger, Guenaelle Levallet, Michèle Legrain, Marie-Odile Joly, Pierre Rivet, Emmanuèle Lechapt Zalcman, François Ducray, Marc Sanson, Audrey Lavenu, Fabienne Escande, Catherine Carpentier, Natacha Entz-Werle, Lucie Karayan-Tapon, Dan Cristian Chiforeanu, Frédéric Fina, Carole Ramirez, Elodie Vauleon
Publikováno v:
Oncotarget
Oncotarget, Impact journals, 2016, 7 (38), pp.61916-61929. ⟨10.18632/oncotarget.11322⟩
Oncotarget, 2016, 7 (38), pp.61916-61929. ⟨10.18632/oncotarget.11322⟩
Oncotarget, Impact journals, 2016, 7 (38), pp.61916-61929. ⟨10.18632/oncotarget.11322⟩
Oncotarget, 2016, 7 (38), pp.61916-61929. ⟨10.18632/oncotarget.11322⟩
International audience; Background: The goal of this prospective multicentric trial was to validate a technique that allowed for MGMT promoter methylation analysis in routine clinical practice.Methods: The MGMT status of 139 glioblastoma patients, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b223e9bd8ea38a7ac1ae3330ea78baa
https://hal.sorbonne-universite.fr/hal-01358205
https://hal.sorbonne-universite.fr/hal-01358205